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Dear Sir,
Bartonella bacilliformis is an autochthonous bacterium 
from rural Andean areas of Peru, Ecuador and Colombia 
affecting less-favoured populations causing the so-called 
Carrion's disease. Carrion's disease is a re-emerging 
illness that has two clinically distinct phases: an acute or 
haematic phase, known as Oroya Fever characterised by 
fever and severe anaemia that may be fatal in the absence 
or delay of antibiotic treatment and an eruptive or tissue 
phase, known as Peruvian Wart1. Additionally, in endemic 
areas, the presence of asymptomatic individuals has been 
reported in whom B. bacilliformis may be recovered or 
detected from blood samples1. 
B. bacilliformis is a fastidious low-growth 
microorganism, requiring blood-enriched media, 
controlled temperature and specific atmospheric 
conditions to grow. Additionally the reported infections 
rates are around 7-20%1. These facts limit the utility of 
bacterial culture as a diagnostic tool.
When Oroya Fever is suspected, the most common 
diagnostic method in endemic Peruvian areas is the Giemsa 
stain of a blood smear, in which the blue-coloured extra or 
intra-erythrocytic bacilli or coco-bacilli can be observed. 
Unfortunately, in centres lacking adequate training in this 
diagnostic technique, the sensitivity can be as low as 36%1. 
The limitations of blood culture together with the potential 
low sensitivity of Giemsa-stained blood smears and the 
severity of the illness usually results in empiric antibiotic 
treatments based on the clinical diagnosis and government 
guidance for treatment of the illness1.
It has been reported that other members of the genus 
Bartonella, such as B. henselae are able to survive more 
than 35 days in red blood cell units stored at 4 ºC, and 
it has also been detected in blood donors and suspicious 
cases of transfusion infections have been described2. 
Meanwhile, B. bacilliformis, contagion by direct contact 
with infected blood or tissues has been reported several 
times either in experimental or accidental manner, 
including at least one case of possible post-transfusion 
acquisition1,3. To our knowledge, only one study from 
1926 reported the ability of B. bacilliformis to survive in 
blood samples of experimentally infected monkeys kept 
at 4 ºC for at least 152 days4. These results suggest that 
the risk of B. bacilliformis infection by transfusion may 
be underestimated, especially when no specific test for 
detection in blood donors is performed in endemic areas. 
Thus, the aim of this report was to assess the ability of 
B. bacilliformis to survive long periods of time in infected 
human blood.
Fifty-five peripheral blood samples of patients with a 
clinical diagnosis of Carrion's disease and a confirmatory 
positive Giemsa-stained blood smear were stored at 4 ºC 
for a minimum of 24 months. Both after collection and 
the end of this storage time, the samples were cultured on 
Columbia Agar adding 10% of sheep blood and incubated 
at 28 ºC for a period of 10 weeks. Every 14 days the plates 
were visually inspected to detect any bacterial growth.
Recovered microorganisms were identified by 
molecular tools. Thus, DNA was extracted using a 
commercial kit (High Pure Template Peparation Kit, 
Roche Applied Science, Germany) and a fragment of 
1503 bp of the 16s RNA gene was amplified as previously 
described5. The amplified products were sequenced 
(Macrogen, Seoul, Korea).
The initial culture showed the growth of 11 out of 55 
samples (20%) after 2-5 weeks of incubation, requiring 
an average of 3.9 weeks to obtain positive growth, while 
after 24-30 months of storage at 4 ºC, 6 out of these 55 
(11%) samples, all belonging to the 11 with previous 
positive cultures (54.5%), showed bacterial growth 
requiring between 4 and 10 weeks of incubation. Thus 2 
out of these 6 cultures were positives after 4 weeks, while 
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the remaining isolates were positive after 6-10 weeks of 
growth (Table I) requiring an average time of 6.6 weeks 
to grow. Thus after storage the average time needed to 
obtain a positive culture was 71% longer that at the time 
of collection. These results suggests the possibility that 
the rate of culture positivity will be increase if incubation 
time is more than 10 weeks. Finally, none of the samples 
in which no growth was observed at the time of collection 
showed any growth after storage at 4 ºC.
In all cases the microorganisms grown were 
morphologically compatible with B. bacilliformis and 
all were identified as B. bacilliformis by analysis of the 
16s RNA gene. 
Although an intensive literature search was performed, 
only clear information of a report of the year 1972 about a 
transfusional acquisition of B. bacilliformis was found. In 
this report a newborn died by Oroya's Fever after receipt 
of a blood transfusion from a family member living 
in a B. bacilliformis endemic area. Although vertical 
transmission has been described in different cases, the 
mother did not have a previous Bartonella infection3. 
In line with this, the present results clearly show the 
risk of long term survival of B. bacilliformis in infected 
human blood stored at 4 ºC, and therefore the potential 
risk of a transfusion transmission of this microorganism. 
This potential risk is enhanced firstly because this 
microorganism requires a prolonged incubation period 
(usually more than 21 days), which exceeds the usual 
period of blood cultivation for detection of bacterial 
infections2, and secondly because of the high rates of 
asymptomatic infections that have been reported in some 
studies1. Thus, it is necessary to reinforce the screening to 
detect B. bacilliformis in blood banks in endemic areas, 
as well as in those of nearby areas due to the interchange 
of population with endemic ones.
As a corollary our results open the door to the 
development of molecular diagnostic tools able to be 
implemented in regional reference centres which might 
test blood samples drawn elsewhere and transported 
under refrigeration conditions. Development of rapid, 
efficient and inexpensive techniques capable of detecting 
B. bacilliformis in blood samples for use in risk areas is 
a current need. To this end several different direct blood 
PCR approaches are currently under investigation by 
our group (unpublished data). These techniques, might 
allow the development of a new and useful clinical 
diagnostic tool and enable screening for the presence of 
B. bacilliformis in banked blood.
In summary, the results demonstrate the ability of 
B. bacilliformis to survive long periods of time in blood 
samples stored at 4 ºC, suggesting the risk of transfusion-
transmitted infections and the need to implement rapid 
techniques to detect infections in donated blood. 
Table I - Microbiological data of the samples.
Sample Initial growth1 Final growth2 Storage3
1 5 weeks 6 weeks 30 months
2 2 weeks 4 weeks 30 months
8 4 weeks 8 weeks 30 months
14 2 weeks Negative 30 months
28 4 weeks Negative 30 months
31 5 weeks Negative 29 months
32 5 weeks Negative 29 months
35 5 weeks 8 weeks 29 months
36 4 weeks Negative 29 months
44 4 weeks 4 weeks 28 months
54 3 weeks 10 weeks 24 months
Legend: 1: time required for growth at collection moment, 2: time 
required for growth after 4 ºC storage, 3: storage time at 4 ºC.
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